All News

Former U.S. president Jimmy Carter provided an update on his health today in a press conference, announcing that he has melanoma.

The FDA has approved Adcetris as a consolidation therapy following autologous stem cell transplantation in patients with Hodgkin lymphoma at risk of relapse or progression, based on the phase 3 AETHERA trial.

An analysis of data collected on thousands of ovarian cancer patients in California turned up some promising news for women with this diagnosis.

Low-grade gliomas may be classified into three distinct prognostic categories based on genomic data.

Adjuvant whole brain radiation therapy (WBRT) dramatically increases the incidence of cognitive decline without survival benefit in patients with small brain metastases from other tumor types.

The investigational agent venetoclax has successfully met the primary endpoint of a phase 2 study as a treatment for patients with high-risk relapsed or refractory chronic lymphocytic leukemia.

A phase 3 trial has demonstrated that treatment with telotristat etiprate can effectively lower the average number of daily bowel movements for individuals with carcinoid syndrome.

Fear of death and dying is explored by a two-time cancer survivor. There are benefits to taking a moment to look at these fears today.

For improved physical function, begin rehab prior to cancer surgery.

Embarking on the genetic testing process can be a toss-up for patients who have cancer or face an elevated risk of developing the disease.